# Single and Multiple Ascending Dose Study of AER-01

> **NCT05862623** · PHASE1 · UNKNOWN · sponsor: **Aer Therapeutics** · enrollment: 72 (estimated)

## Conditions studied

- COPD

## Interventions

- **DRUG:** AER-01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05862623
- **Lead sponsor:** Aer Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-26
- **Primary completion:** 2024-08
- **Final completion:** 2024-08
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2024-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05862623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05862623, "Single and Multiple Ascending Dose Study of AER-01". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05862623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*